New blood test could unlock better treatment for stubborn liver viruses
NCT ID NCT06372990
Summary
This study aims to develop a faster blood test that measures the immune system's response in people with chronic hepatitis B and D. Researchers will observe 300 patients over time to see how their immune cells relate to their disease status and treatment outcomes. The goal is to create a tool that helps doctors better understand and manage these liver infections in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.
RECRUITINGMilan, MI, 20122, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.